Status:
COMPLETED
Sleep Disturbances as a Non-traditional Risk Factor in CKD-Actigraphy
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
University of Illinois at Chicago
Case Western Reserve University
Conditions:
Chronic Kidney Disease
Sleep Loss
Eligibility:
All Genders
21-74 years
Brief Summary
To test if usual at home night time sleep duration as measured with activity monitors and questionnaires will predict changes in kidney function as measured by kidney filtration rate and of cardiovasc...
Eligibility Criteria
Inclusion
- Mild to Moderate CKD
- Healthy controls age and gender matched to CKD subjects
- Regular bedtimes of at least 6h/night, sedentary lifestyle
Exclusion
- Diabetes
- Current or previous dialysis for more than 1 month
- Uncontrolled hypertension
- Heart failure
- Liver disease
- HIV
- Hemoglobin \< 10.5 g/dl
- Treatment with EProcrit, Epogen, or Aranesp
- Bone or organ transplant,
- Use of immunosuppressive drugs within past 6 months
- Current oral contraceptive use
- Current pregnancy
- Chemotherapy for malignancy within past 2 years
Key Trial Info
Start Date :
November 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
353 Patients enrolled
Trial Details
Trial ID
NCT00817674
Start Date
November 1 2007
End Date
October 1 2010
Last Update
September 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Chicago
Chicago, Illinois, United States, 60637